@charlyguardia.bsky.socialđź‘‹ Click the link below and check the new issue of the #PlacentalCellBio report by @biomednews.bsky.social #Cuproptosis #EVs #Preeclampsia
Subscribe to receive weekly issues of this report by going to biomed.news/bims-placeb!
@ptmbio.bsky.socialA recent study published in Cell identified MYH9 as a key executioner of cuproptosis, revealing a previously uncharacterized downstream mechanism of copper-dependent cell death.
Read the paper:https://doi.org/10.1016/j.cell.2026.08.030
#Cuproptosis #Acetylation #PTM #Proteomics #CancerResearch #Cell
@sigtrans-sttt.bsky.socialHow do #Cuproptosis and #Ferroptosis intersect across disease?
This review connects metal metabolism, redox imbalance, organelle crosstalk, and regulatory networks with therapeutic strategies, #Biomarkers, and patient stratification.
#STTT #OpenAccess: doi.org/10.1038/s413...
#PrecisionOncology
@medchemexpress.bsky.social#MYH9 Emerges as a Key Executor of #Cuproptosis
A new study in Cell identifies MYH9 as a key executioner of cuproptosis, a copper-dependent form of cell death.
🧫Copper binds MYH9 → MYH9 polymerization → Cytoskeleton disruption → Cell death
@elementjournal.bsky.socialScientific Exploration Seminar
Join Prof. Qiao Wu (Xiamen University) for a special lecture on cuproptosis, MYH9, and endogenous copper homeostasis.
📅 Sept. 28 | 19:00–20:00 (UTC+8)
💻 Online | 🗣️ Chinese
#Cuproptosis #MYH9 #CopperHomeostas
@fudiwang.bsky.social @haoyin.bsky.social
@sigtrans-sttt.bsky.socialCan copper dependence become a therapeutic vulnerability in #Cancer? This review explores copper homeostasis, #Cuproptosis mechanisms, tumor–immune interactions, #Biomarkers, and emerging copper- and cuproptosis-targeted therapies.